Max discusses the intriguing potential of intranasal insulin as a treatment for Alzheimer's disease, highlighting its ability to bypass the blood-brain barrier and improve cognitive functions. He explains how insulin's role in the brain differs from its function in the body, and raises questions about the long-term effects of chronic use. The conversation delves into the complexities of memory types and the implications of insulin resistance in Alzheimer's patients.
